Success Stories: With Our Meticulous Efforts, A Postdoctoral Research Associate from Nigeria Working in the Field of Neuroscience Achieved NIW Approval.

Posted by wegreened on June 21, 2023 in NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“Thank you for your professional and effective service.”

On February 15^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Neuroscience (Approval Notice).

General Field: Neuroscience

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: Nigeria

State of Residence at the Time of Filing: Virginia

Approval Notice Date: February 15^th, 2023

Processing Time: 12 days (Premium Processing Requested)

Case Summary:

Based on the huge number of successful cases, North America Immigration Law Group has developed the most up-to-date winning strategies for the NIW category, which enable us to offer our “Approval or Refund” services to many of the NIW cases we take. However, there are certain prerequisites to be fulfilled by an individual including:

The foreign national must be in a position to advance the proposed endeavor.
The applicant must present evidence that the U.S. would benefit on balance to waive the job offer criteria for an EB-2.
A proposed endeavor, holding substantial merit and national importance.

Therefore, through our expertise and based on the above requirements, we prepared a convincing case for our client hailing from Nigeria, currently positioned as a postdoctoral research associate after completing his Ph.D. in physiology (neurophysiology). His petition packet included the following key essentials:

His research advancing his proposed endeavor is of great importance because it works to provide insight into crucial mechanisms that lead to the onset of common neurological diseases in order to aid the design of new therapies and treatments and thus his efforts are relevant to helping the United States address the serious public health and economic issues posed by long COVID.
His work has resulted in 12 peer-reviewed journal articles (6 of them first-authored) and is cited 105 times according to Google Scholar.
His work has received funding from the National Institutes of Health (NIH), the leading funder for biomedical research within the U.S. government.
His research is further given detailed importance by two of his fellow experts in the field of neuroscience.

As the documentary evidence and corroborating testimony from experts in the field establish, our client is a member of the professions holding an advanced degree. He proposes to continue his research on investigating microglial-vascular interaction and cerebral blood flow regulation in order to improve treatments for neurological diseases, which is clearly an endeavor with substantial merit and national importance. Also, thanks to premium processing, he received his I-140 NIW approval in 12 days only. We are proud of having worked with him and are grateful to him for his continued trust in us.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%